140 related articles for article (PubMed ID: 3958353)
1. Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
Sokoloff NM; Spielman SR; Greenspan AM; Rae AP; Brady PM; Kay HR; Horowitz LN
J Am Coll Cardiol; 1986 Apr; 7(4):938-41. PubMed ID: 3958353
[TBL] [Abstract][Full Text] [Related]
2. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy.
Veltri EP; Reid PR; Platia EV; Griffith LS
J Am Coll Cardiol; 1985 Oct; 6(4):806-13. PubMed ID: 3928726
[TBL] [Abstract][Full Text] [Related]
4. Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Feb; 9(2):398-404. PubMed ID: 3805529
[TBL] [Abstract][Full Text] [Related]
5. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
[TBL] [Abstract][Full Text] [Related]
6. The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone.
Veltri EP; Griffith LS; Platia EV; Guarnieri T; Reid PR
Circulation; 1986 Nov; 74(5):1054-60. PubMed ID: 3769165
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
[TBL] [Abstract][Full Text] [Related]
8. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
Vazquez Blanco M; Milei J; Piñeiro DJ; Buceta JE; Dreyer MP
Acta Cardiol; 1983; 38(2):125-32. PubMed ID: 6603085
[TBL] [Abstract][Full Text] [Related]
9. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
[TBL] [Abstract][Full Text] [Related]
10. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal.
Lavery D; Saksena S
Am Heart J; 1987 Jan; 113(1):49-56. PubMed ID: 3799441
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
Manolis AS; Uricchio F; Estes NA
Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease.
Nasir N; Doyle TK; Wheeler SH; Pacifico A
Am J Cardiol; 1994 Mar; 73(8):554-8. PubMed ID: 7511872
[TBL] [Abstract][Full Text] [Related]
13. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
J Am Coll Cardiol; 1985 Sep; 6(3):539-44. PubMed ID: 2411776
[TBL] [Abstract][Full Text] [Related]
14. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
Naccarelli GV; Fineberg NS; Zipes DP; Heger JJ; Duncan G; Prystowsky EN
J Am Coll Cardiol; 1985 Oct; 6(4):814-21. PubMed ID: 3928727
[TBL] [Abstract][Full Text] [Related]
15. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
Mason JW
N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
[TBL] [Abstract][Full Text] [Related]
17. Serum reverse T3 and amiodarone efficacy.
Haberman RJ; Ladenson PW; Griffith LS; Veltri EP
Clin Cardiol; 1989 Mar; 12(3):140-4. PubMed ID: 2466595
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings.
Rasmussen K; Winkle R; Ross D; Griffin J; Peters F; Mason J
Acta Med Scand; 1982; 212(6):367-74. PubMed ID: 6760675
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
Morady F; Scheinman MM; Hess DS
Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
[TBL] [Abstract][Full Text] [Related]
20. [Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up].
Di Pede F; Raviele A; Gasparini G; Caprioglio F; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1990 Sep; 20(9):819-27. PubMed ID: 2079183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]